1 Report Overview 1.1 Study Scope 1.2 Market Analysis by Type 1.2.1 Global Xenotransplantation Market Size Growth Rate by Type: 2017 VS 2021 VS 2028 1.2.2 Organ Preservation Solutions 1.2.3 Transplant Diagnostics 1.2.4 Tissue Products 1.3 Market by Application 1.3.1 Global Xenotransplantation Market Share by Application: 2017 VS 2021 VS 2028 1.3.2 Hospital 1.3.3 Transplant Center 1.3.4 Other 1.4 Study Objectives 1.5 Years Considered 2 Global Growth Trends 2.1 Global Xenotransplantation Market Perspective (2017-2028) 2.2 Xenotransplantation Growth Trends by Region 2.2.1 Xenotransplantation Market Size by Region: 2017 VS 2021 VS 2028 2.2.2 Xenotransplantation Historic Market Size by Region (2017-2022) 2.2.3 Xenotransplantation Forecasted Market Size by Region (2023-2028) 2.3 Xenotransplantation Market Dynamics 2.3.1 Xenotransplantation Industry Trends 2.3.2 Xenotransplantation Market Drivers 2.3.3 Xenotransplantation Market Challenges 2.3.4 Xenotransplantation Market Restraints 3 Competition Landscape by Key Players 3.1 Global Top Xenotransplantation Players by Revenue 3.1.1 Global Top Xenotransplantation Players by Revenue (2017-2022) 3.1.2 Global Xenotransplantation Revenue Market Share by Players (2017-2022) 3.2 Global Xenotransplantation Market Share by Company Type (Tier 1, Tier 2, and Tier 3) 3.3 Players Covered: Ranking by Xenotransplantation Revenue 3.4 Global Xenotransplantation Market Concentration Ratio 3.4.1 Global Xenotransplantation Market Concentration Ratio (CR5 and HHI) 3.4.2 Global Top 10 and Top 5 Companies by Xenotransplantation Revenue in 2021 3.5 Xenotransplantation Key Players Head office and Area Served 3.6 Key Players Xenotransplantation Product Solution and Service 3.7 Date of Enter into Xenotransplantation Market 3.8 Mergers & Acquisitions, Expansion Plans 4 Xenotransplantation Breakdown Data by Type 4.1 Global Xenotransplantation Historic Market Size by Type (2017-2022) 4.2 Global Xenotransplantation Forecasted Market Size by Type (2023-2028) 5 Xenotransplantation Breakdown Data by Application 5.1 Global Xenotransplantation Historic Market Size by Application (2017-2022) 5.2 Global Xenotransplantation Forecasted Market Size by Application (2023-2028) 6 North America 6.1 North America Xenotransplantation Market Size (2017-2028) 6.2 North America Xenotransplantation Market Size by Country (2017-2022) 6.3 North America Xenotransplantation Market Size by Country (2023-2028) 6.4 United States 6.5 Canada 7 Europe 7.1 Europe Xenotransplantation Market Size (2017-2028) 7.2 Europe Xenotransplantation Market Size by Country (2017-2022) 7.3 Europe Xenotransplantation Market Size by Country (2023-2028) 7.4 Germany 7.5 France 7.6 U.K. 7.7 Italy 7.8 Russia 7.9 Nordic Countries 8 Asia-Pacific 8.1 Asia-Pacific Xenotransplantation Market Size (2017-2028) 8.2 Asia-Pacific Xenotransplantation Market Size by Country (2017-2022) 8.3 Asia-Pacific Xenotransplantation Market Size by Country (2023-2028) 8.4 China 8.5 Japan 8.6 South Korea 8.7 Southeast Asia 8.8 India 8.9 Australia 9 Latin America 9.1 Latin America Xenotransplantation Market Size (2017-2028) 9.2 Latin America Xenotransplantation Market Size by Country (2017-2022) 9.3 Latin America Xenotransplantation Market Size by Country (2023-2028) 9.4 Mexico 9.5 Brazil 10 Middle East & Africa 10.1 Middle East & Africa Xenotransplantation Market Size (2017-2028) 10.2 Middle East & Africa Xenotransplantation Market Size by Country (2017-2022) 10.3 Middle East & Africa Xenotransplantation Market Size by Country (2023-2028) 10.4 Turkey 10.5 Saudi Arabia 10.6 UAE 11 Key Players Profiles 11.1 Sino-Clone Organ Biotechnology 11.1.1 Sino-Clone Organ Biotechnology Company Detail 11.1.2 Sino-Clone Organ Biotechnology Business Overview 11.1.3 Sino-Clone Organ Biotechnology Xenotransplantation Introduction 11.1.4 Sino-Clone Organ Biotechnology Revenue in Xenotransplantation Business (2017-2022) 11.1.5 Sino-Clone Organ Biotechnology Recent Development 11.2 Qihan Biotech 11.2.1 Qihan Biotech Company Detail 11.2.2 Qihan Biotech Business Overview 11.2.3 Qihan Biotech Xenotransplantation Introduction 11.2.4 Qihan Biotech Revenue in Xenotransplantation Business (2017-2022) 11.2.5 Qihan Biotech Recent Development 11.3 Grand Life Science & Technology 11.3.1 Grand Life Science & Technology Company Detail 11.3.2 Grand Life Science & Technology Business Overview 11.3.3 Grand Life Science & Technology Xenotransplantation Introduction 11.3.4 Grand Life Science & Technology Revenue in Xenotransplantation Business (2017-2022) 11.3.5 Grand Life Science & Technology Recent Development 11.4 Geneo 11.4.1 Geneo Company Detail 11.4.2 Geneo Business Overview 11.4.3 Geneo Xenotransplantation Introduction 11.4.4 Geneo Revenue in Xenotransplantation Business (2017-2022) 11.4.5 Geneo Recent Development 11.5 Terumo Medical Corporation 11.5.1 Terumo Medical Corporation Company Detail 11.5.2 Terumo Medical Corporation Business Overview 11.5.3 Terumo Medical Corporation Xenotransplantation Introduction 11.5.4 Terumo Medical Corporation Revenue in Xenotransplantation Business (2017-2022) 11.5.5 Terumo Medical Corporation Recent Development 11.6 Transonic 11.6.1 Transonic Company Detail 11.6.2 Transonic Business Overview 11.6.3 Transonic Xenotransplantation Introduction 11.6.4 Transonic Revenue in Xenotransplantation Business (2017-2022) 11.6.5 Transonic Recent Development 11.7 Roche 11.7.1 Roche Company Detail 11.7.2 Roche Business Overview 11.7.3 Roche Xenotransplantation Introduction 11.7.4 Roche Revenue in Xenotransplantation Business (2017-2022) 11.7.5 Roche Recent Development 11.8 Astellas Pharma 11.8.1 Astellas Pharma Company Detail 11.8.2 Astellas Pharma Business Overview 11.8.3 Astellas Pharma Xenotransplantation Introduction 11.8.4 Astellas Pharma Revenue in Xenotransplantation Business (2017-2022) 11.8.5 Astellas Pharma Recent Development 11.9 Preservation Solutions 11.9.1 Preservation Solutions Company Detail 11.9.2 Preservation Solutions Business Overview 11.9.3 Preservation Solutions Xenotransplantation Introduction 11.9.4 Preservation Solutions Revenue in Xenotransplantation Business (2017-2022) 11.9.5 Preservation Solutions Recent Development 11.10 OrganOX Limited 11.10.1 OrganOX Limited Company Detail 11.10.2 OrganOX Limited Business Overview 11.10.3 OrganOX Limited Xenotransplantation Introduction 11.10.4 OrganOX Limited Revenue in Xenotransplantation Business (2017-2022) 11.10.5 OrganOX Limited Recent Development 11.11 Bio-Med (P) Limited 11.11.1 Bio-Med (P) Limited Company Detail 11.11.2 Bio-Med (P) Limited Business Overview 11.11.3 Bio-Med (P) Limited Xenotransplantation Introduction 11.11.4 Bio-Med (P) Limited Revenue in Xenotransplantation Business (2017-2022) 11.11.5 Bio-Med (P) Limited Recent Development 11.12 TransMedic 11.12.1 TransMedic Company Detail 11.12.2 TransMedic Business Overview 11.12.3 TransMedic Xenotransplantation Introduction 11.12.4 TransMedic Revenue in Xenotransplantation Business (2017-2022) 11.12.5 TransMedic Recent Development 11.13 Novartis AG 11.13.1 Novartis AG Company Detail 11.13.2 Novartis AG Business Overview 11.13.3 Novartis AG Xenotransplantation Introduction 11.13.4 Novartis AG Revenue in Xenotransplantation Business (2017-2022) 11.13.5 Novartis AG Recent Development 11.14 Organ Recovery Systems 11.14.1 Organ Recovery Systems Company Detail 11.14.2 Organ Recovery Systems Business Overview 11.14.3 Organ Recovery Systems Xenotransplantation Introduction 11.14.4 Organ Recovery Systems Revenue in Xenotransplantation Business (2017-2022) 11.14.5 Organ Recovery Systems Recent Development 11.15 Accord Healthcare 11.15.1 Accord Healthcare Company Detail 11.15.2 Accord Healthcare Business Overview 11.15.3 Accord Healthcare Xenotransplantation Introduction 11.15.4 Accord Healthcare Revenue in Xenotransplantation Business (2017-2022) 11.15.5 Accord Healthcare Recent Development 11.16 Pfizer 11.16.1 Pfizer Company Detail 11.16.2 Pfizer Business Overview 11.16.3 Pfizer Xenotransplantation Introduction 11.16.4 Pfizer Revenue in Xenotransplantation Business (2017-2022) 11.16.5 Pfizer Recent Development 11.17 Veloxis Pharmaceuticals 11.17.1 Veloxis Pharmaceuticals Company Detail 11.17.2 Veloxis Pharmaceuticals Business Overview 11.17.3 Veloxis Pharmaceuticals Xenotransplantation Introduction 11.17.4 Veloxis Pharmaceuticals Revenue in Xenotransplantation Business (2017-2022) 11.17.5 Veloxis Pharmaceuticals Recent Development 12 Analyst's Viewpoints/Conclusions 13 Appendix 13.1 Research Methodology 13.1.1 Methodology/Research Approach 13.1.2 Data Source 13.2 Disclaimer 13.3 Author Details

List of Tables Table 1. Global Xenotransplantation Market Size Growth Rate by Type (US$ Million): 2017 VS 2021 VS 2028 Table 2. Key Players of Organ Preservation Solutions Table 3. Key Players of Transplant Diagnostics Table 4. Key Players of Tissue Products Table 5. Global Xenotransplantation Market Size Growth by Application (US$ Million): 2017 VS 2021 VS 2028 Table 6. Global Xenotransplantation Market Size by Region (US$ Million): 2017 VS 2021 VS 2028 Table 7. Global Xenotransplantation Market Size by Region (2017-2022) & (US$ Million) Table 8. Global Xenotransplantation Market Share by Region (2017-2022) Table 9. Global Xenotransplantation Forecasted Market Size by Region (2023-2028) & (US$ Million) Table 10. Global Xenotransplantation Market Share by Region (2023-2028) Table 11. Xenotransplantation Market Trends Table 12. Xenotransplantation Market Drivers Table 13. Xenotransplantation Market Challenges Table 14. Xenotransplantation Market Restraints Table 15. Global Xenotransplantation Revenue by Players (2017-2022) & (US$ Million) Table 16. Global Xenotransplantation Market Share by Players (2017-2022) Table 17. Global Top Xenotransplantation Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Xenotransplantation as of 2021) Table 18. Ranking of Global Top Xenotransplantation Companies by Revenue (US$ Million) in 2021 Table 19. Global 5 Largest Players Market Share by Xenotransplantation Revenue (CR5 and HHI) & (2017-2022) Table 20. Key Players Headquarters and Area Served Table 21. Key Players Xenotransplantation Product Solution and Service Table 22. Date of Enter into Xenotransplantation Market Table 23. Mergers & Acquisitions, Expansion Plans Table 24. Global Xenotransplantation Market Size by Type (2017-2022) & (US$ Million) Table 25. Global Xenotransplantation Revenue Market Share by Type (2017-2022) Table 26. Global Xenotransplantation Forecasted Market Size by Type (2023-2028) & (US$ Million) Table 27. Global Xenotransplantation Revenue Market Share by Type (2023-2028) Table 28. Global Xenotransplantation Market Size by Application (2017-2022) & (US$ Million) Table 29. Global Xenotransplantation Revenue Market Share by Application (2017-2022) Table 30. Global Xenotransplantation Forecasted Market Size by Application (2023-2028) & (US$ Million) Table 31. Global Xenotransplantation Revenue Market Share by Application (2023-2028) Table 32. North America Xenotransplantation Market Size by Country (2017-2022) & (US$ Million) Table 33. North America Xenotransplantation Market Size by Country (2023-2028) & (US$ Million) Table 34. Europe Xenotransplantation Market Size by Country (2017-2022) & (US$ Million) Table 35. Europe Xenotransplantation Market Size by Country (2023-2028) & (US$ Million) Table 36. Asia-Pacific Xenotransplantation Market Size by Region (2017-2022) & (US$ Million) Table 37. Asia-Pacific Xenotransplantation Market Size by Region (2023-2028) & (US$ Million) Table 38. Latin America Xenotransplantation Market Size by Country (2017-2022) & (US$ Million) Table 39. Latin America Xenotransplantation Market Size by Country (2023-2028) & (US$ Million) Table 40. Middle East & Africa Xenotransplantation Market Size by Country (2017-2022) & (US$ Million) Table 41. Middle East & Africa Xenotransplantation Market Size by Country (2023-2028) & (US$ Million) Table 42. Sino-Clone Organ Biotechnology Company Detail Table 43. Sino-Clone Organ Biotechnology Business Overview Table 44. Sino-Clone Organ Biotechnology Xenotransplantation Product Table 45. Sino-Clone Organ Biotechnology Revenue in Xenotransplantation Business (2017-2022) & (US$ Million) Table 46. Sino-Clone Organ Biotechnology Recent Development Table 47. Qihan Biotech Company Detail Table 48. Qihan Biotech Business Overview Table 49. Qihan Biotech Xenotransplantation Product Table 50. Qihan Biotech Revenue in Xenotransplantation Business (2017-2022) & (US$ Million) Table 51. Qihan Biotech Recent Development Table 52. Grand Life Science & Technology Company Detail Table 53. Grand Life Science & Technology Business Overview Table 54. Grand Life Science & Technology Xenotransplantation Product Table 55. Grand Life Science & Technology Revenue in Xenotransplantation Business (2017-2022) & (US$ Million) Table 56. Grand Life Science & Technology Recent Development Table 57. Geneo Company Detail Table 58. Geneo Business Overview Table 59. Geneo Xenotransplantation Product Table 60. Geneo Revenue in Xenotransplantation Business (2017-2022) & (US$ Million) Table 61. Geneo Recent Development Table 62. Terumo Medical Corporation Company Detail Table 63. Terumo Medical Corporation Business Overview Table 64. Terumo Medical Corporation Xenotransplantation Product Table 65. Terumo Medical Corporation Revenue in Xenotransplantation Business (2017-2022) & (US$ Million) Table 66. Terumo Medical Corporation Recent Development Table 67. Transonic Company Detail Table 68. Transonic Business Overview Table 69. Transonic Xenotransplantation Product Table 70. Transonic Revenue in Xenotransplantation Business (2017-2022) & (US$ Million) Table 71. Transonic Recent Development Table 72. Roche Company Detail Table 73. Roche Business Overview Table 74. Roche Xenotransplantation Product Table 75. Roche Revenue in Xenotransplantation Business (2017-2022) & (US$ Million) Table 76. Roche Recent Development Table 77. Astellas Pharma Company Detail Table 78. Astellas Pharma Business Overview Table 79. Astellas Pharma Xenotransplantation Product Table 80. Astellas Pharma Revenue in Xenotransplantation Business (2017-2022) & (US$ Million) Table 81. Astellas Pharma Recent Development Table 82. Preservation Solutions Company Detail Table 83. Preservation Solutions Business Overview Table 84. Preservation Solutions Xenotransplantation Product Table 85. Preservation Solutions Revenue in Xenotransplantation Business (2017-2022) & (US$ Million) Table 86. Preservation Solutions Recent Development Table 87. OrganOX Limited Company Detail Table 88. OrganOX Limited Business Overview Table 89. OrganOX Limited Xenotransplantation Product Table 90. OrganOX Limited Revenue in Xenotransplantation Business (2017-2022) & (US$ Million) Table 91. OrganOX Limited Recent Development Table 92. Bio-Med (P) Limited Company Detail Table 93. Bio-Med (P) Limited Business Overview Table 94. Bio-Med (P) Limited XenotransplantationProduct Table 95. Bio-Med (P) Limited Revenue in Xenotransplantation Business (2017-2022) & (US$ Million) Table 96. Bio-Med (P) Limited Recent Development Table 97. TransMedic Company Detail Table 98. TransMedic Business Overview Table 99. TransMedic XenotransplantationProduct Table 100. TransMedic Revenue in Xenotransplantation Business (2017-2022) & (US$ Million) Table 101. TransMedic Recent Development Table 102. Novartis AG Company Detail Table 103. Novartis AG Business Overview Table 104. Novartis AG XenotransplantationProduct Table 105. Novartis AG Revenue in Xenotransplantation Business (2017-2022) & (US$ Million) Table 106. Novartis AG Recent Development Table 107. Organ Recovery Systems Company Detail Table 108. Organ Recovery Systems Business Overview Table 109. Organ Recovery Systems XenotransplantationProduct Table 110. Organ Recovery Systems Revenue in Xenotransplantation Business (2017-2022) & (US$ Million) Table 111. Organ Recovery Systems Recent Development Table 112. Accord Healthcare Company Detail Table 113. Accord Healthcare Business Overview Table 114. Accord Healthcare XenotransplantationProduct Table 115. Accord Healthcare Revenue in Xenotransplantation Business (2017-2022) & (US$ Million) Table 116. Accord Healthcare Recent Development Table 117. Pfizer Company Detail Table 118. Pfizer Business Overview Table 119. Pfizer XenotransplantationProduct Table 120. Pfizer Revenue in Xenotransplantation Business (2017-2022) & (US$ Million) Table 121. Pfizer Recent Development Table 122. Veloxis Pharmaceuticals Company Detail Table 123. Veloxis Pharmaceuticals Business Overview Table 124. Veloxis Pharmaceuticals XenotransplantationProduct Table 125. Veloxis Pharmaceuticals Revenue in Xenotransplantation Business (2017-2022) & (US$ Million) Table 126. Veloxis Pharmaceuticals Recent Development Table 127. Research Programs/Design for This Report Table 128. Key Data Information from Secondary Sources Table 129. Key Data Information from Primary Sources List of Figures Figure 1. Global Xenotransplantation Market Share by Type: 2021 VS 2028 Figure 2. Organ Preservation Solutions Features Figure 3. Transplant Diagnostics Features Figure 4. Tissue Products Features Figure 5. Global Xenotransplantation Market Share by Application in 2021 & 2028 Figure 6. Hospital Case Studies Figure 7. Transplant Center Case Studies Figure 8. Other Case Studies Figure 9. Xenotransplantation Report Years Considered Figure 10. Global Xenotransplantation Market Size (US$ Million), Year-over-Year: 2017-2028 Figure 11. Global Xenotransplantation Market Size, (US$ Million), 2017 VS 2021 VS 2028 Figure 12. Global Xenotransplantation Market Share by Region: 2021 VS 2028 Figure 13. Global Xenotransplantation Market Share by Players in 2021 Figure 14. Global Top Xenotransplantation Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Xenotransplantation as of 2021) Figure 15. The Top 10 and 5 Players Market Share by Xenotransplantation Revenue in 2021 Figure 16. North America Xenotransplantation Market Size YoY Growth (2017-2028) & (US$ Million) Figure 17. North America Xenotransplantation Market Share by Country (2017-2028) Figure 18. United States Xenotransplantation Market Size YoY Growth (2017-2028) & (US$ Million) Figure 19. Canada Xenotransplantation Market Size YoY Growth (2017-2028) & (US$ Million) Figure 20. Europe Xenotransplantation Market Size YoY Growth (2017-2028) & (US$ Million) Figure 21. Europe Xenotransplantation Market Share by Country (2017-2028) Figure 22. Germany Xenotransplantation Market Size YoY Growth (2017-2028) & (US$ Million) Figure 23. France Xenotransplantation Market Size YoY Growth (2017-2028) & (US$ Million) Figure 24. U.K. Xenotransplantation Market Size YoY Growth (2017-2028) & (US$ Million) Figure 25. Italy Xenotransplantation Market Size YoY Growth (2017-2028) & (US$ Million) Figure 26. Russia Xenotransplantation Market Size YoY Growth (2017-2028) & (US$ Million) Figure 27. Nordic Countries Xenotransplantation Market Size YoY Growth (2017-2028) & (US$ Million) Figure 28. Asia-Pacific Xenotransplantation Market Size YoY Growth (2017-2028) & (US$ Million) Figure 29. Asia-Pacific Xenotransplantation Market Share by Region (2017-2028) Figure 30. China Xenotransplantation Market Size YoY Growth (2017-2028) & (US$ Million) Figure 31. Japan Xenotransplantation Market Size YoY Growth (2017-2028) & (US$ Million) Figure 32. South Korea Xenotransplantation Market Size YoY Growth (2017-2028) & (US$ Million) Figure 33. Southeast Asia Xenotransplantation Market Size YoY Growth (2017-2028) & (US$ Million) Figure 34. India Xenotransplantation Market Size YoY Growth (2017-2028) & (US$ Million) Figure 35. Australia Xenotransplantation Market Size YoY Growth (2017-2028) & (US$ Million) Figure 36. Latin America Xenotransplantation Market Size YoY Growth (2017-2028) & (US$ Million) Figure 37. Latin America Xenotransplantation Market Share by Country (2017-2028) Figure 38. Mexico Xenotransplantation Market Size YoY Growth (2017-2028) & (US$ Million) Figure 39. Brazil Xenotransplantation Market Size YoY Growth (2017-2028) & (US$ Million) Figure 40. Middle East & Africa Xenotransplantation Market Size YoY Growth (2017-2028) & (US$ Million) Figure 41. Middle East & Africa Xenotransplantation Market Share by Country (2017-2028) Figure 42. Turkey Xenotransplantation Market Size YoY Growth (2017-2028) & (US$ Million) Figure 43. Saudi Arabia Xenotransplantation Market Size YoY Growth (2017-2028) & (US$ Million) Figure 44. Sino-Clone Organ Biotechnology Revenue Growth Rate in Xenotransplantation Business (2017-2022) Figure 45. Qihan Biotech Revenue Growth Rate in Xenotransplantation Business (2017-2022) Figure 46. Grand Life Science & Technology Revenue Growth Rate in Xenotransplantation Business (2017-2022) Figure 47. Geneo Revenue Growth Rate in Xenotransplantation Business (2017-2022) Figure 48. Terumo Medical Corporation Revenue Growth Rate in Xenotransplantation Business (2017-2022) Figure 49. Transonic Revenue Growth Rate in Xenotransplantation Business (2017-2022) Figure 50. Roche Revenue Growth Rate in Xenotransplantation Business (2017-2022) Figure 51. Astellas Pharma Revenue Growth Rate in Xenotransplantation Business (2017-2022) Figure 52. Preservation Solutions Revenue Growth Rate in Xenotransplantation Business (2017-2022) Figure 53. OrganOX Limited Revenue Growth Rate in Xenotransplantation Business (2017-2022) Figure 54. Bio-Med (P) Limited Revenue Growth Rate in Xenotransplantation Business (2017-2022) Figure 55. TransMedic Revenue Growth Rate in Xenotransplantation Business (2017-2022) Figure 56. Novartis AG Revenue Growth Rate in Xenotransplantation Business (2017-2022) Figure 57. Organ Recovery Systems Revenue Growth Rate in Xenotransplantation Business (2017-2022) Figure 58. Accord Healthcare Revenue Growth Rate in Xenotransplantation Business (2017-2022) Figure 59. Pfizer Revenue Growth Rate in Xenotransplantation Business (2017-2022) Figure 60. Veloxis Pharmaceuticals Revenue Growth Rate in Xenotransplantation Business (2017-2022) Figure 61. Bottom-up and Top-down Approaches for This Report Figure 62. Data Triangulation Figure 63. Key Executives Interviewed

Sino-Clone Organ Biotechnology Qihan Biotech Grand Life Science & Technology Geneo Terumo Medical Corporation Transonic Roche Astellas Pharma Preservation Solutions OrganOX Limited Bio-Med (P) Limited TransMedic Novartis AG Organ Recovery Systems Accord Healthcare Pfizer Veloxis Pharmaceuticals